By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NanoString Technologies Inc. 

201 Elliott Avenue West
Suite 300
Seattle  Washington  98119  U.S.A.
Phone: 206-378-NANO Fax: 206-378-6288



Company News
NanoString (NSTG) Enters Into Collaboration Agreement With Medivation (MDVN) And Astellas (ALPMY) To Develop Novel Companion Diagnostic Test 1/11/2016 1:55:41 PM
NanoString (NSTG) Touts Collaborative Work in Immuno-Oncology at J.P. Morgan Conference 1/11/2016 11:00:31 AM
NanoString (NSTG) Announces Eleven Prosigna/PAM50 Presentations At The 2015 CTRC-AACR San Antonio Breast Cancer Symposium 12/7/2015 8:15:07 AM
NanoString (NSTG) To Present At Canaccord Genuity Medical Technology And Diagnostics Forum 11/6/2015 7:50:58 AM
NanoString (NSTG) Expands 3D Biology Portfolio With The Commercial Launch Of Seven New Ncounter Pancancer Profiles To Deeply Probe Cancer Biology 11/5/2015 12:08:13 PM
NanoString (NSTG) To Release Third Quarter 2015 Financial Results And Host Conference Call On Monday, November 2, 2015 10/13/2015 8:09:17 AM
NanoString (NSTG) Expands Immuno-Oncology Portfolio With Commercial Launch Of Innovative Ncounter RNA:Protein Pancancer Immune Profiling Panel 9/11/2015 7:06:33 AM
NanoString (NSTG) To Unveil Strategic Roadmap For Growth And Market Expansion 9/11/2015 6:58:58 AM
NanoString (NSTG) Release: ESMO Clinical Practice Guidelines For Breast Cancer Recommend The Use Of Prosigna/PAM50 Assay For Determining Potential Benefit From Chemotherapy 9/9/2015 7:50:59 AM
NanoString (NSTG) To Present At Upcoming Investor Conferences 8/27/2015 7:14:44 AM